News Release

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Kyowa Hakko Kirin News Releases 2015

December 18, 2015
Launch of the Web Comic "The Story of Basic Immunology"
December 8, 2015
Kyowa Medex Launched "Liaison 25 -hydroxyvitamin D Total" in Japan
December 3, 2015
Kyowa Hakko Kirin Announces Initiation of Global Phase 3 Study of KRN23 in Adults with X-Linked Hypophosphatemia (XLH)PDF file:New window opens(70KB)
December 2, 2015
Kyowa Hakko Kirin Announces Positive Interim 40-Week Data from Pediatric Phase 2 Study of KRN23 in X-Linked HypophosphatemiaPDF file:New window opens(41KB)
December 1, 2015
Kyowa Hakko Kirin Announces Commencement of Phase 3 Clinical Study of KHK7580 in Patients with Secondary Hyperparathyroidism in Japan
October 28, 2015
Consolidated Financial Summary Fiscal 2015 Third QuarterPDF file:New window opens(110KB)
October 28, 2015
Appendix to the Consolidated Financial Summary Fiscal 2015 Third QuarterPDF file:New window opens(255KB)
October 28, 2015
Notice Concerning Change of the Number of Shares to Constitute One Unit Share and Partial Amendment to the Articles of IncorporationPDF file:New window opens(89KB)
July 31, 2015
Consolidated Financial Summary Fiscal 2015 InterimPDF file:New window opens(113KB)
July 31, 2015
Appendix to the Consolidated Financial Summary Fiscal 2015 InterimPDF file:New window opens(249KB)
July 31, 2015
Results Presentation Fiscal 2015 InterimPDF file:New window opens(1,036KB)
July 30, 2015
Kyowa Hakko Kirin Submits Application for Approval in Japan for Brodalumab (KHK4827)
July 30, 2015
Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S.PDF file:New window opens(96KB)
July 28, 2015
Kyowa Hakko Kirin initiated a Pivotal Phase 3 Trial of Benralizumab (KHK4563) for COPD in Japan
July 27, 2015
Launch of Reconfigured Kyowa Hakko Kirin Global Website
July 24, 2015
Kyowa Hakko Kirin Revises ForecastsPDF file:New window opens(39KB)
July 24, 2015
Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca to develop and commercialise anti-VEGF biosimilarPDF file:New window opens(85KB)
July 23, 2015
Kyowa Hakko Kirin Announces Results of the Phase 3 Studies of KHK4827 in Subjects with Psoriasis in Japan
July 16, 2015
Kyowa Hakko Kirin Enters Option Agreement with AstraZeneca for Commercialisation of Benralizumab (KHK4563) in JapanPDF file:New window opens(58KB)
July 3, 2015
Approval for ACOALAN® in Japan
June 26, 2015
New window opensCantargia licenses BioWa POTELLIGENT® Technology platform for production of lead product candidate PDF file:New window opens(492KB)
June 16, 2015
Launch of REGPARA® Tablets 12.5mg in Japan
April 28, 2015
Consolidated Financial Summary Fiscal 2015 First QuarterPDF file:New window opens(108KB)
April 28, 2015
Appendix to the Consolidated Financial Summary Fiscal 2015 First QuarterPDF file:New window opens(204KB)
April 9, 2015
Completion of Construction for Amino Acid Manufacturing Plant in Thailand
April 1, 2015
Entries Now Publicly Available from the "Commitment to Life" Contest Movie!
Movies show the philosophy of employees across the Kyowa Hakko Kirin Group
March 31, 2015
Completion of Construction for New Research Building in Fuji Research Park
March 31, 2015
Matters concerning controlling shareholdersPDF file:New window opens(41KB)
March 20, 2015
Notice regarding allotment of stock acquisition rights(stock compensation-type stock options)PDF file:New window opens(43KB)
March 16, 2015
Change in the Company Name (trade name) at DAIICHI FINE CHEMICAL CO., LTD.
March 5, 2015
Kyowa Hakko Kirin Announces Commencement of Phase 2 Clinical Study of RTA 402 in CKD patients with type 2 diabetes in Japan
February 17, 2015
Position and policies concerning the reduction of the minimum investment unitPDF file:New window opens(24KB)
February 17, 2015
Notice regarding stock acquisition rights for the purpose of granting stock compensation-type stock optionsPDF file:New window opens(19KB)
February 17, 2015
Transfer of BioWa's "External Innovation Engine" In-Licensing Activities to Kyowa Hakko Kirin California
February 16, 2015
Approval of REGPARA® Tablets 12.5mg in JapanPDF file:New window opens(28KB)
January 30, 2015
Consolidated Financial Summary Fiscal 2014PDF file:New window opens(318KB)
January 30, 2015
Appendix to the Consolidated Financial Summary Fiscal 2014PDF file:New window opens(226KB)
January 30, 2015
Results Presentation Fiscal 2014PDF file:New window opens(1,568KB)
January 30, 2015
Change of Representative Directors at Kyowa Hakko BioPDF file:New window opens(31KB)
January 8, 2015
Kyowa Hakko Kirin and Syndax Announce an Exclusive License Agreement to Develop and Commercialize Entinostat in Japan and KoreaPDF file:New window opens(52KB)

Get Adobe® Reader®You need Adobe® Reader® to view these documents.
Download Adobe® Reader® of Adobe Systems here.



To Page Top